Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Syncope in childhood.

K A McLeod1

  • 1Department of Cardiology, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow G3 8SJ, UK. karen.mcleod@yorkhill.scot.nhs.uk

Archives of Disease in Childhood
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detecting small-scale genotype-environment interactions in apomictic dandelion (Taraxacum officinale) populations.

Journal of evolutionary biology·2012
Same author

Hypoglycaemic syncope in children secondary to beta-blockers.

Archives of disease in childhood·2009
Same author

Dizziness and syncope in adolescence.

Heart (British Cardiac Society)·2001
Same author

Dysautonomia and neurocardiogenic syncope.

Current opinion in cardiology·2001
Same author

Images in cardiology. Growth and the implantable cardioverter defibrillator.

Heart (British Cardiac Society)·2000
Same author

Myocardial perfusion scanning in patients considered for late arterial switch.

Cardiology in the young·2000
Same journal

Protecting adolescent confidentiality in the digital age: a global call for adolescent-informed electronic health records.

Archives of disease in childhood·2026
Same journal

Diagnostic accuracy study assessing the ability of paediatric asthma scores to predict admission following initial emergency department bronchodilator therapy: a Clinical Asthma Scoring systems in Paediatric Emergency (CASPER) study.

Archives of disease in childhood·2026
Same journal

Artificial intelligence for child health: current capabilities and the next frontier.

Archives of disease in childhood·2026
Same journal

Troubled origins and lasting impact of the first insulin injection.

Archives of disease in childhood·2026
Same journal

Paediatric readiness assessment tools in emergency care: a scoping review.

Archives of disease in childhood·2026
Same journal

Building a paediatric workforce to deliver the NHS prevention agenda: time for paediatric public health medicine?

Archives of disease in childhood·2026
See all related articles

Childhood syncope is common and usually benign, often caused by neurocardiogenic syncope. Diagnosis relies on history, with reassurance and lifestyle changes as primary management for most cases.

Area of Science:

  • Pediatric Cardiology
  • Neurology

Background:

  • Syncope (fainting) is a frequent occurrence in childhood.
  • Most childhood syncope episodes are benign and self-limiting.
  • A small percentage of cases may indicate serious or life-threatening underlying conditions.

Purpose of the Study:

  • To differentiate benign causes of syncope from more serious ones in pediatric patients.
  • To outline diagnostic and management strategies for childhood syncope.

Main Methods:

  • Diagnosis is primarily based on detailed patient history.
  • Clinical evaluation is key to differentiating causes.
  • Investigations are often not fruitful in identifying the cause.

Main Results:

Related Experiment Videos

  • Neurocardiogenic syncope is the most common cause of benign fainting in children.
  • History is the most effective tool for diagnosis.
  • Serious causes are rare but require prompt identification.

    • Conclusions:

    • Reassurance and increased dietary fluid and salt intake are the mainstays of management for neurocardiogenic syncope.
    • Pharmacological treatment is reserved for severe, frequent attacks.
    • Cardiac pacemakers are indicated only for extremely severe, drug-refractory cases.